Mitsui to Acquire Sumitomo Pharma Animal Health
Shots:
- Mitsui acquired all shares in Sumitomo Pharma Animal Health with a share capital of $1.49M/ ¥200M (as of Sep 2022). The acquisition is expected to be completed in Q1’2024
- After the completion of the share transfer, Sumitomo Pharma Animal Health (SPAH) and Marupi Lifetech (subsidiary of SPAH) will no longer be subsidiary of Sumitomo Pharma
- The acquisition will lead to the development of global animal health business and advance introduction of foreign products and license exporting by creating synergies with Mitsui’s business assets including the companion, livestock, and aquatic animal business inside and outside Japan
Ref: Mitsui | Image: Mitsui
Related posts:- Anzac Animal Health’s Zycosan Receives the US FDA’s Approval as First Injectable
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
